Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002031 · ClinicalTrials.gov registry record · NA
Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
NCT00002031 is a NA study that has completed, run by University of California, San Francisco.
The verdict
NCT00002031, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate the effect of application of Dinitrochlorobenzene (DNCB) on the number, morphology, and antigen expression of epidermal Langerhans cells in AIDS and AIDS related complex (ARC) patients.
Interventions
- DRUG Dinitrochlorobenzene
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002031
The ClinicalTrials.gov registry entry for NCT00002031 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dinitrochlorobenzene is the first listed.
NCT00002031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002031 about?
NCT00002031 is a clinical study titled "Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)". To evaluate the effect of application of Dinitrochlorobenzene (DNCB) on the number, morphology, and antigen expression of epidermal Langerhans cells in AIDS and AIDS related complex (ARC) patients.
What is the current status of trial NCT00002031?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002031?
The interventions under investigation include: Dinitrochlorobenzene (DRUG).
Who is sponsoring clinical trial NCT00002031?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.